These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

488 related items for PubMed ID: 4205524

  • 1. Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.
    Branch RA, Shand DG, Wilkinson GR, Nies AS.
    J Clin Invest; 1974 Apr; 53(4):1101-7. PubMed ID: 4205524
    [Abstract] [Full Text] [Related]

  • 2. Effect of butalbital and phenobarbital pretreatment on antipyrine clearance in the rat.
    Tse FL, Chang T, Jaffe JM.
    Arch Int Pharmacodyn Ther; 1986 Feb; 279(2):181-94. PubMed ID: 3963935
    [Abstract] [Full Text] [Related]

  • 3. Increase in hepatic blood flow and d-propranolol clearance by glucagon in the monkey.
    Branch RA, Shand DG, Nies AS.
    J Pharmacol Exp Ther; 1973 Dec; 187(3):581-7. PubMed ID: 4203721
    [No Abstract] [Full Text] [Related]

  • 4. Interactions of phenobarbital with propranolol in the dog. 2. Bioavailability, metabolism and pharmacokinetics.
    Vu VT, Bai SA, Abramson FP.
    J Pharmacol Exp Ther; 1983 Jan; 224(1):55-61. PubMed ID: 6848749
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Beta-adrenergic blockade affects initial drug distribution due to decreased cardiac output and altered blood flow distribution.
    Avram MJ, Krejcie TC, Henthorn TK, Niemann CU.
    J Pharmacol Exp Ther; 2004 Nov; 311(2):617-24. PubMed ID: 15197245
    [Abstract] [Full Text] [Related]

  • 7. Phenobarbital in the genetically obese Zucker rat. II. In vivo and in vitro assessments of microsomal enzyme induction.
    Brouwer KL, Kostenbauder HB, McNamara PJ, Blouin RA.
    J Pharmacol Exp Ther; 1984 Dec; 231(3):654-9. PubMed ID: 6502519
    [Abstract] [Full Text] [Related]

  • 8. Effects of route of administration and blood flow on hepatic drug elimination.
    Shand DG, Kornhauser DM, Wilkinson GR.
    J Pharmacol Exp Ther; 1975 Dec; 195(3):424-32. PubMed ID: 1195129
    [Abstract] [Full Text] [Related]

  • 9. Hemodynamic drug interactions.
    Nies AS, Shand DG, Branch RA.
    Cardiovasc Clin; 1974 Dec; 6(2):43-53. PubMed ID: 4613462
    [No Abstract] [Full Text] [Related]

  • 10. Reduced hepatic clearance of propranolol induced by chronic carbon tetrachloride treatment in rats.
    Iwamoto K, Watanabe J, Araki K, Satoh M, Deguchi N.
    J Pharmacol Exp Ther; 1985 Aug; 234(2):470-5. PubMed ID: 4020680
    [Abstract] [Full Text] [Related]

  • 11. Influence of rifampicin, phenobarbital and cimetidine on mixed function monooxygenase in extensive and poor metabolizers of debrisoquine.
    Leclercq V, Desager JP, Horsmans Y, Van Nieuwenhuyze Y, Harvengt C.
    Int J Clin Pharmacol Ther Toxicol; 1989 Dec; 27(12):593-8. PubMed ID: 2613393
    [Abstract] [Full Text] [Related]

  • 12. On the antipyrine test in laboratory animals. Studies in the dog and monkey.
    Vickers FF, Bowman TA, Dvorchik BH, Passananti GT, Hughes DM, Vesell ES.
    Drug Metab Dispos; 1989 Dec; 17(2):160-5. PubMed ID: 2565205
    [Abstract] [Full Text] [Related]

  • 13. Effects of chronic phenobarbital on verapamil disposition in humans.
    Rutledge DR, Pieper JA, Mirvis DM.
    J Pharmacol Exp Ther; 1988 Jul; 246(1):7-13. PubMed ID: 3392664
    [Abstract] [Full Text] [Related]

  • 14. The hemodynamic effects of beta adrenergic blockade on the flow-dependent hepatic clearance of propranolol.
    Nies AS, Evans GH, Shand DG.
    J Pharmacol Exp Ther; 1973 Mar; 184(3):716-20. PubMed ID: 4631471
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pharmacokinetic profile of antipyrine in young rhesus monkeys (Macaca mulatta) with protein energy malnutrition.
    Sharma B, Mehta S, Nain CK, Mathur VS.
    Drug Nutr Interact; 1985 Mar; 3(2):93-8. PubMed ID: 3921335
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Alteration of the pharmacokinetics and metabolism of propranolol and antipyrine elicited by indwelling catheters in the rat.
    Chindavijak B, Belpaire FM, De Smet F, Bogaert MG.
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1075-9. PubMed ID: 3418510
    [Abstract] [Full Text] [Related]

  • 19. Effect of Fluosol-DA hemodilution on the kinetics of hepatically eliminated drugs.
    Shrewsbury RP.
    Res Commun Chem Pathol Pharmacol; 1987 Mar; 55(3):375-96. PubMed ID: 3575876
    [Abstract] [Full Text] [Related]

  • 20. Intact hepatocyte theory of impaired drug metabolism in experimental cirrhosis in the rat.
    Wood AJ, Villeneuve JP, Branch RA, Rogers LW, Shand DG.
    Gastroenterology; 1979 Jun; 76(6):1358-62. PubMed ID: 437433
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.